Reviewing Prestige Consumer Healthcare Inc. (PBH)’s and Cutera Inc. (NASDAQ:CUTR)’s results

As Medical Appliances & Equipment businesses, Prestige Consumer Healthcare Inc. (NYSE:PBH) and Cutera Inc. (NASDAQ:CUTR), are affected by contrast. This especially applies to their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Prestige Consumer Healthcare Inc. 990.72M 1.49 63.79M 1.23 23.34
Cutera Inc. 162.72M 1.44 30.77M -2.21 0.00

Table 1 showcases the gross revenue, earnings per share (EPS) and valuation of Prestige Consumer Healthcare Inc. and Cutera Inc.


Table 2 provides us the return on equity, net margins and return on assets of both companies.

Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare Inc. 6.44% 5.4% 1.7%
Cutera Inc. -18.91% 37.4% 22.4%

Volatility and Risk

A beta of 0.97 shows that Prestige Consumer Healthcare Inc. is 3.00% less volatile than Standard & Poor’s 500. Cutera Inc.’s 0.72 beta is the reason why it is 28.00% less volatile than Standard & Poor’s 500.


2.3 and 1.3 are the respective Current Ratio and a Quick Ratio of Prestige Consumer Healthcare Inc. Its rival Cutera Inc.’s Current and Quick Ratios are 1.9 and 1.2 respectively. Prestige Consumer Healthcare Inc. has a better chance of clearing its pay short and long-term debts than Cutera Inc.

Analyst Recommendations

Recommendations and Ratings for Prestige Consumer Healthcare Inc. and Cutera Inc. can be find in next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Prestige Consumer Healthcare Inc. 0 1 0 2.00
Cutera Inc. 0 0 1 3.00

On the other hand, Cutera Inc.’s potential upside is 49.34% and its consensus target price is $25.

Institutional & Insider Ownership

The shares of both Prestige Consumer Healthcare Inc. and Cutera Inc. are owned by institutional investors at 45.06% and 95.6% respectively. Prestige Consumer Healthcare Inc.’s share owned by insiders are 0.1%. On the other hand, insiders owned about 1.8% of Cutera Inc.’s shares.


In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Prestige Consumer Healthcare Inc. -1.31% 2.58% -25.99% -26.62% -15.09% -7.25%
Cutera Inc. 2.59% 21.59% -16.14% -45.69% -61.96% 2.59%

For the past year Prestige Consumer Healthcare Inc. has -7.25% weaker performance while Cutera Inc. has 2.59% stronger performance.


Prestige Consumer Healthcare Inc. beats on 8 of the 12 factors Cutera Inc.

Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning segments. The companyÂ’s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies. Its OTC healthcare products portfolio also comprise Fess nasal saline sprays, Hydralyte for dehydration and electrolyte replacement, Monistat for vaginal treatment-anti-fungal, Nix lice/parasite treatments, DenTek for peg oral care, Summer's Eve feminine care products, Fleet laxatives, Pedia Lax pediatric laxatives, Ecotrin aspirin, Phazyme for gas relief, Tagamet acid reducers, and Uristat urinary tract infection treatments. The company also offers household cleaning products consisting of Chore Boy scrubbing Pads; Comet abrasive and non-abrasive powders, sprays, and creams; and Spic and Span brand products. It primarily offers its products to mass merchandisers, drug stores, and supermarkets, as well as club, convenience, and dollar stores. The company was founded in 1996 and is headquartered in Tarrytown, New York.

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.